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1. Introduction 
Sepsis is defined as the combination of pathologic infection and physiological changes 
known collectively as the systemic inflammatory response syndrome (Martin, 2003). This 
response results in physiological alterations that occur at the capillary endothelial level. In 
the early stages, the clinical manifestations of this process are unspecific and it is often 
underappreciated in clinical practice. However, early recognition of this syndrome is vital to 
reducing mortality in sepsis. 
From clinical studies sepsis can be seen as a continuum of severity that begins with an 
infection, followed in some cases by sepsis, severe sepsis – with organ dysfunction – and 
septic shock. There has been a substantial increase in the incidence of sepsis during the last 
decades, and it appears to be rising over time, with an increasing number of deaths 
occurring despite a decline in overall in-hospital mortality (Bone, 1992). Advanced age, 
underlying comorbidities and number of organ dysfunction are factors which are 
consistently associated with higher mortality in severe sepsis and septic shock. 
In this chapter we are going to review the definitions of sepsis syndromes, the factors  
that have contributed to the widening of physicians’ awareness of sepsis, severe sepsis  
and septic shock; the incidence of severe sepsis and septic shock; the epidemiological  
data of patients with severe sepsis and septic shock in the emergency departments and 
intensive care units; the causative microorganisms, and the changes observed over recent 
years. 
2. Definitions 
The concept of sepsis syndrome originated during the time of Hippocrates. But it was not 
until the nineteenth century when Sir William Osler recognized that “except on few 
occasions, the patient appears to die from the body’s response to infection rather than to the 
infection” (Hodgkin, 2008). During a long period of time great confusion existed as to the 
description of systemic inflammatory response to infection, and several terms were used 
www.intechopen.com
 
Severe Sepsis and Septic Shock – Understanding a Serious Killer 
 
4 
interchangeably: septicemia, sepsis, sepsis syndrome and septic shock. In clinical practice 
sepsis is the most confusing term used to describe the body’s systemic response to infection, 
and to many clinicians sepsis implies a life-threatening state. 
 
Bacteremia The presence of viable bacteria in the blood 
SIRS The systemic inflammatory response to a variety of severe 
clinical insults which is manifested by two or more of the 
following conditions: 
 
(1) temperature >38ºC or <36ºC 
(2) heart rate >90 beats per minute 
(3) respiratory rate >20 breaths per minute or PaCO2 <32 
mm Hg 
(4) white blood cell count >12,000/cu mm, <4,000/cu 
mm, or >10% immature (band) forms 
 
Sepsis The systemic inflammatory response (SIRS) as a result of 
infection 
Severe Sepsis Sepsis associated with organ dysfunction, hypoperfusion, or 
hypotension. Hypoperfusion and perfusion abnormalities may 
include, but are not limited to lactic acidosis, oliguria, or an 
acute alteration in mental status 
Septic Shock Sepsis-induced with hypotension despite adequate  
fluid resuscitation along with the presence of  
perfusion abnormalities that may include, but are not  
limited to, lactic acidosis, oliguria, or an acute alteration  
in mental status. Patients who are receiving  
inotropic or vasopressor agents may not be hypotensive  
at the time that perfusion abnormalities are  
measured. 
Table 1. Definition of bacteremia, SIRS, sepsis, severe sepsis and septic shock. 
In 1991, the American College of Chest Physicians and the Society of Critical Care Medicine 
convened a Consensus Conference and the definitions of sepsis syndromes were published 
in order to clarify the terminology used to describe the body's systemic responses to 
infection (Bone, 1992). These definitions are easy to use, based on clinical data of the 
patients, and describe a clinical continuum response to infection. 
In the opinion of the authors of this chapter these definitions have not only been widely 
used in practice and clinical trials of therapeutic interventions but they have greatly 
contributed to the recognition of these syndromes. Before analyzing the epidemiology of 
severe sepsis and septic shock the reader should be familiarized with all these terms. The 
definitions of bacteremia, systemic inflammatory response syndrome (SIRS), sepsis, severe 
sepsis and septic shock are shown in table 1, and the relationships between infection, 
systemic inflammatory response syndrome (SIRS) and septic syndromes are shown in figure 1.  
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Fig. 1. The relationship between infection, systemic inflammatory response syndrome (SIRS) 
and sepsis syndromes. 
In 2001, an International Sepsis Definitions Conference (Levy, 2003; Dunne, 2003) was 
sponsored by the Society of Critical Care Medicine (SCCM), the European Society of 
Intensive Care Medicine (ESICM), the American College of Chest Physicians (ACCP), the 
American Thoracic Society (ATS), and the Surgical Infection Society (SIS) to revisit the 1992 
sepsis guidelines. Based on this conference a consensus document was developed, 
concluding that there was not enough evidence to support a change to the previous 
definitions. This document expanded the list of signs and symptoms of sepsis to reflect 
clinical bedside experience. Besides, the document developed a classification scheme for 
sepsis, called PIRO (Predisposition, Insult infection, Response, Organ dysfunction), that will 
stratify patients on the basis of their predisposing conditions, the nature and extent of the 
insult (in the case of sepsis, infection), the nature and magnitude of the host response, and 
the degree of concomitant organ dysfunction. This has provided a basis for introducing 
PIRO as a hypothesis-generating model for future research. 
Predisposition (P) was the new element which was added to the IRO model proposed by 
John Marshall and based on the TNM system used in oncology patients. Factors that 
predispose patients to outcome in sepsis include genetic factors, environment, cultural 
factors and pre-existing diseases.  
Infections (I) have four categories with a significant impact on outcome: The site, extent, 
source (hospital vs. community-acquired, etc) and type of organism. Besides, the immune 
status of a patient is related with opportunistic infections, which are associated with worse 
prognosis.  
Response (R) is affected by several factors, such as: age, type of invading microorganism, 
genotype and co-morbidities. The use of biomarkers to stratify the degree of response is one 
of the most promising elements for diagnosis and risk assessment in the future. Given the 
complexity of the immune response in sepsis a single static measurement of a biomarker 
(pro-calcitonin or any other biomarker) may not be as important as a dynamic assessment of 
change over time.  
The level of organ dysfunction is similar to the presence of metastatic disease in cancer. The 
evaluation of organ dysfunction has evolved from describing it in all-or-nothing terms to 
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use organ failures scores to describe the degree of organ dysfunction developing over the 
course of critical illness.  
The participants in this conference gave priority to the facilitation of bedside diagnosis over 
standardized sepsis entry criteria for clinical trials. The conclusions of this conference can be 
summarized as: 1) The current concepts of sepsis, severe sepsis, and septic shock seem to be 
robust definitions and should remain as described 10 yrs ago. 2) Current definitions do not 
allow for precise staging of the host response to infection. 3) Signs and symptoms of sepsis 
are more varied than the initial criteria established in 1991. 4) A list of these signs and 
symptoms, for the diagnosis of sepsis is presented. 5) The future lies in developing a staging 
system that will characterize progression of sepsis. A new system, PIRO, is proposed for 
characterizing and staging the host response to infection. 
The diagnostic criteria for sepsis in adults are shown in table 2. The definition of Systemic 
Inflammatory Response Syndrome (SIRS) in pediatrics is defined as: “The presence of two 
or more of the following criteria, one of which must be abnormal temperature or leukocyte 
count: a) Core temperature of > 38.5ºC or < 36ºC. b) Tachycardia, defined as a mean heart  
 
 
Documented o suspected Infection and some of the folloging:
- General variables Fever (core temperature >38.3°C)
Hypothermia (core temperature <36°C) 
Heart rate >90 min 
Tachypnea 
Altered mental status 
Significant edema or positive fluid balance (>20 mL/kg 
over 24 hrs) 
Hyperglycemia (plasma glucose >120 mg/dL or 7.7 
mmol/L) in the absence of diabetes
- Inflammatory variables Leukocytosis (WBC count >12,000 µL-1)
Leukopenia (WBC count <4000 µL-1) 
Normal WBC count with >10% immature forms 
Plasma C-reactive protein>2 SD above the normal value 
Plasma procalcitonin >2 SD above the normal value 
- Hemodynamic variables Arterial hypotension (SBP <90 mm Hg, MAP <70, or an 
SBP decrease >40 mm Hg  
SvO2 >70% 
Cardiac index >3.5 L.min-1.M-23
- Organ dysfunction variables Arterial hypoxemia (PaO2/FIO2 <300)
Acute oliguria (urine output <0.5 mL.kg-1.hr-1 or 45 
mmol/L for at least 2 hrs) 
Creatinine increase >0.5 mg/dL 
Coagulation abnormalities (INR >1.5 or aPTT >60 secs) 
Ileus (absent bowel sounds) 
Thrombocytopenia (platelet count <100,000 µL-1) 
Hyperbilirubinemia (plasma total bilirubin >4 mg/dL 
or 70 mmol/L)
   - Tissue perfusion variables Hyperlactatemia (>1 mmol/L)
Decreased capillary refill or mottling
Table 2. Diagnostic criteria for sepsis in aduts 
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rate > 2 sd above normal for age in the absence of external stimulus, chronic drugs, or 
painful stimuli; or otherwise unexplained persistent elevation over a 0.5- to 4-hour time 
period or for children < 1 year old: Bradycardia, defined as a mean heart rate < 10th 
percentile for age in the absence of external vagal stimulus, beta-blocker drugs, or congenital 
heart disease; or otherwise unexplained persistent depression over a 0.5-hour time period. c) 
Mean respiratory rate > 2 sd above normal for age or mechanical ventilation for an acute 
process not related to underlying neuromuscular disease or the receipt of general 
anesthesia. d) Leukocyte count elevated or depressed for age (not secondary to 
chemotherapy-induced leukopenia) or > 10% immature neutrophils. 
Criteria for sepsis in the pediatric population are different: arterial hypotension is defined as 
<2 SD below normal for age; neither SvO2 >70% nor cardiac index >3.5 L.min-1.M-23 should 
be used as signs of sepsis in newborns or children. Diagnostic criteria for sepsis in the 
pediatric population are signs and symptoms of inflammation plus infection with rectal 
temperature >38.5 or <35°C, tachycardia (may be absent in hypothermic patients), and at 
least one of the following indications of altered organ function: altered mental status, 
hypoxemia, increased serum lactate level, or bounding pulses. 
A bedside diagnosis of sepsis is not frequently base only on these criteria. Instead, experienced 
clinicians consider some physical and laboratory finding that prompt them to conclude that an 
infected patient “looks septic”.  These findings include general variables (altered mental status, 
significant edema …), inflammatory variables (plasma C-reactive protein, plasma 
procalcitonin …), hemodynamic variables (arterial hypotension, SvO2 …), organ dysfunction 
variables (arterial hypoxemia, acute oliguria, coagulation abnormalities …), and tissue 
perfusion variables (decreased capillary refill or mottling, hyperlactatemia).  
In summary, the definitions of sepsis, severe sepsis and septic shock established in 1992 are 
useful to clinicians and researchers. However they are not precise tools to predict the 
outcomes of these syndromes, so the inclusion of clinical, microbiological and biological 
factors in clinical practice may aid to better characterize the prognosis of sepsis. Further 
evidence is needed to support changes in the current definitions of sepsis.  
3. Incidence of severe sepsis and septic shock  
The epidemiology of sepsis, severe sepsis and septic shock is not well known due to the 
absence of population base prospective cohort studies, and to the fact that most of the 
studies on the epidemiology of sepsis are based on hospital discharge diagnoses which do 
not use the consensus definitions. The incidence of severe sepsis and septic shock has 
notably increased in recent years, and appears to be rising over time (figure 2). 
A comparison of population incidence and hospital prevalence of severe sepsis reported 
from several studies is shown in table 3. 
In 1990, the Centers for Disease Control (CDC), based on data from the National Hospital 
Discharge Survey, estimated that there were 450,000 cases of sepsis per year in the United 
States (CDC, 1990). Angus, using ICD-9-CM codes, in a large observational cohort study 
(n=6,621,559) in the United States in 1995, identified 192,980 cases of severe sepsis which 
represents an estimated incidence of 3.0 cases per 1,000 population, 2.26 cases per 100 
hospital discharges, and 11 percent of all admissions to the ICU (Angus, 2001). However, the 
accuracy of ICD-9-CM coding for the identification of specific medical conditions remains 
controversial, and Martin (Martin, 2003) suggested that Angus’s estimates may overstate the 
incidence of severe sepsis by as much as a factor of two to four. 
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Martin et al. (Martin, 2003) identified 10,319,418 cases of sepsis from an estimated 750 
million hospitalizations in the United States over a 22-yr period, with an increase in 
frequency from 82.7 cases per 100,000 population in 1979 to 240.4 cases per 100,000 
population in 2000, therefore there was an annualized increase in the incidence of sepsis of 
8.7 percent. 
 
 
Country 
 
Author, yr 
Prevalence in 
hospital per 
100 admissions 
Prevalence in 
ICUs per 100 
ICU 
admissions 
Estimated 
incidence per 
100,000 
population 
Australia Sundarajan, 
2005 
4.3 NR 76 
Australia & 
N.Zeland 
Finfer, 2004 
- 11.8 77 
Europe Alberti, 2001 - 15.5 - 
Europe Vincet, 2006 - 30.0 - 
Finland Karlsson, 2007 - 10.5 69 
France Brun-Buisson, 
1995 
2.9 11.9 - 
France Episepsis, 2004 - 14.6 95 
Germany Engel, 2006 - 11.0 76 
Netherlands Van Gestel, 
2004 
- 11.0 54 
Norway Flaatten, 2004 3 - 48 
United 
Kingdom 
Padkin, 2003 
- 27.1 51 
Spain Esteban, 2007 12.4 - 104 
USA Angus, 2001 2.6 11 300 
USA Martin, 2003 4.7 - 81 
Table 3. Prevalence of severe sepsis in several studies around the world. ( Adapted from 
Brun-Buisson C. Impact of Sepsis on Public Health. In: Dellinger P, Carlet J, editors. Sepsis 
handbook. 1st ed. Marcy l’Etoile: Editons Biomerieux;2009. p. 8-17). 
In a recent prospective, observational study in Iceland, the incidence of severe sepsis and 
septic shock was 0.48 per 1,000 inhabitants ≥18 years of age per year [95% confidence 
intervals (CI) 0.42-0.55] (Vesteinsdottir, 2011). 
The Italian SEPSIS study found that in 99 ICUs the prevalence of SIRS, sepsis, severe sepsis 
and septic shock in patients admitted to ICUs were  58%, 16%, 5% and 6%, respectively 
(Salvo, 1995). These and other results provide evidence of how the progression from sepsis 
to septic shock follows a continuum. 
In an international multicenter cohort study on sepsis and infection in intensive care unit 
patients (Artigas 2002), infections had a crude incidence of 21.1%. Among 3,034 infectious 
episodes 24% were associated with severe sepsis and 30% with septic shock. The frequency 
of septic shock is increasing with more multiresistant strains. Annane et al analyzed the 
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epidemiology of septic shock from 100,554 intensive care unit admissions and found that the 
frequency of septic shock increased from 7.0 per 100 admissions in 1993 to 9.7 per 100 
admissions in 2000 (Annane, 2003).  
 
 
Fig. 2. Incidence of septic shock. Data collected over an 8-year period from 22 hospitals 
(adapted from Annane et al Am J Respir Crit Care Med 2003; 168:165-72). 
Using the Emergency Department data of 2001-2004 from the National Hospital Ambulatory 
Medical Care Survey, and applying the 2003 international consensus criteria, Wang et al 
(Wang 2007) estimated the burden of severe sepsis in Emergency Departments as more than 
500,000 adult patients per year, with individual patients spending an average of almost 5 hrs 
in the Emergency Department. Due to limitations of the study, such as not having access to 
data of respiratory rate, the true number of cases may be even higher.  
Most cases of severe sepsis occur in patients who are already hospitalized for other reasons. 
In a series of 166 patients with bloodstream infections admitted to an intensive care unit we 
found that 82.5% of  patients had nosocomial acquired infections, and the nosocomial origin 
of the bacteremia was associated with inadequate empirical antimicrobial treatment 
(Zaragoza, 2003). 
Dombrovskiy et al. used the NIS to show that from 1993 to 2003, the age-adjusted rate of 
hospitalization for severe sepsis increased from 66.8 to 132.0 cases per 100,000 persons 
(Dombrovskiy, 2007).   
Sepsis remains a significant cause of morbidity and mortality in pediatric population. 
Watson et al (Watson, 2003) using 1995 hospital discharge and population data from seven 
states analyzed the incidence of severe sepsis in children in the United States (see figure 3). 
The incidence was highest in infants (5.16 cases per 1000) and over 20% were low birth 
weight neonates. The respiratory tract (37%) and primary bloodstream infections (25%) were 
the most common sources of infection. 
Sepsis is an important source of postoperative morbidity and mortality. Recently, Bateman 
et al studied the temporal trends in the epidemiology of severe postoperative sepsis after 
elective surgery in patients aged 18 years or older for any of the 20 most common primary 
procedure types who had a length of stay more than 3 days from the NIS dataset for the 
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years 1997–2006, and found that the rate of severe sepsis increased from 0.3% in 1997 to 0.9% 
in 2006. This trend persisted after adjusting for relevant covariables—the adjusted odds ratio 
of severe sepsis per year increase in the study period was 1.12 (95% CI, 1.11–1.13; P _ 0.001) 
(Bateman, 2010).  Abdominal surgery has been described as the most prevalent class of 
surgical procedure in severe postoperative sepsis. The reasons for the increased rate of 
severe postoperative sepsis are unknown, but possible causes are an increase in the 
proportion of infections caused by resistant microorganisms and an increase in the 
comorbidities that predispose to sepsis. 
 
 
Fig. 3. Annual incidence of severe sepsis by age in the pediatric population of the United 
States (Modified from Watson RS et al. The epidemiology of severe sepsis in children in the 
United States. Am J Respir Crit Care Med 2003;167:695–701). 
4. Epidemiological data of patients     
Age 
There is a direct relationship between advanced age and the incidence of severe sepsis y 
septic shock, with a sharp increase in incidence in elderly people (Wang, 2007; Angus, 2001). 
The incidence of severe sepsis in infants is also elevated, with an annual rate of 5.3 cases per 
1,000 population (Angus, 2001).  
The median age of patients with severe sepsis in most studies is between 60 to 65 years, and 
when the patients are stratified at the age of 65, the relative risk for sepsis was 13 times 
higher for patients aged 65 and above. Martin et al (Martin, 2006) found that the incidence 
rates of sepsis increased 20.4% faster among older patients 65 years of age or older than 
among younger patients from 1979 to 2002 (mean increase per year, 11.5% versus 9.5%; 
P<.001). Epidemiological studies analyzing data from the 1990s found an increased 
incidence of severe sepsis in young people, especially men in their thirties, which could be 
attributed to patients with human immunodeficiency virus related conditions. However, the 
better control of the HIV epidemic in developed countries is changing this trend.   
Gram-negative microorganisms are more frequent in older patients than in younger 
patients. Escherichia coli has found to be the most common microorganism in patients older 
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than 65 years, whereas Staphylococcus aureus was the most frequent microorganism in 
younger patients with community acquired bacteremia (Diekema, 2002). Likewise, the 
source of infection has also been different among older patients with sepsis than among 
younger patients. Urinary tract infection is more frequently the source of sepsis in older 
patients than in younger patients. 
 
 
Fig. 4. Rate of severe postoperative sepsis after elective surgery by year (adapted from 
Bateman, Anesthesiology 2010). 
The relationship between age and incidence of severe sepsis and septic shock in a series of 
455 adult patients with these disorders admitted to an ICU at the Hospital Universitario Dr. 
Peset, in Valencia (Spain) is shown in figure 5.  
 
 
Fig. 5. Relationship between the incidence of severe sepsis and septic shock and patient’s 
age in a series of 455 cases with these disorders admitted to ICU at the Hospital 
Universitario Dr. Peset, Valencia, Spain. 
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Race 
Epidemiologic studies have shown a higher incidence of severe sepsis and septic shock in 
black people, suggesting a possible genetic predisposition. Alternatively, a higher 
prevalence of renal disease and diabetes in the black population might explain the higher 
incidence of these syndromes (Mayr 2010; Martin 2003).  
Besides, a higher incidence of severe sepsis and septic shock in black people could be related 
to the higher percentage of black people living in poverty. Otherwise, the mean age of black 
people has been found to be lower in black people than in white people.  
A higher infection rate and a higher risk of acute organ dysfunction in black as compared  
to white individuals could explain racial differences in severe sepsis (Mayr 2010).  
Lastly, race specific genetic polymorphisms in the host response to infection may predispose 
certain racial groups to increased incidence or worse outcomes with sepsis (Berkowitz  
2007). 
 
 
Fig. 6. Relationship between gender and the incidence of severe sepsis and septic shock 
according to the patient’s age in a series of 455 cases with these disorders admitted to ICU 
(see text). 
Sex 
Men are more likely than women to develop sepsis, with a mean annual relative risk of  
1.28 (95% CI 1.24-1.32) (Martin, 2003). However, it is not clear whether this difference  
could be due to a higher prevalence of comorbidities in men, or whether women are 
protected against the inflammatory changes that occur in severe sepsis and septic shock 
(Angus, 2001).  
2001; Martin, 2003). Female gender has been found to substantially decrease the risk for 
developing severe sepsis, independent of other patient and surgical risk factors, after 
elective surgery (Bateman, 2010). 
In figures 5 and 6 are shown the distribution of severe sepsis and septic shock according to 
gender and age in a series of 455 patients with these disorders admitted to an ICU at the 
Hospital Universitario Dr. Peset in Valencia (Spain). 
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The absence of a link between the incidence of severe sepsis and menopause argues against 
the gender differences being solely mediated through sex hormones. Also, women appear to 
have a lower rate of age-adjusted severe sepsis as a consequence of fewer episodes of 
respiratory origin (Angus 2001).  
The sources of infections in severe sepsis are different between genders. Women are more 
likely than men to have genitourinary infections urinary tract infections, whereas men are 
more likely to have respiratory infections, but other sources of sepsis appears to have a 
similar distribution. 
Comorbidities 
Patients with severe sepsis and septic shock frequently have underlying comorbidities 
which predispose them to infections and may have an additive contribution to mortality.  
McCabe classification has been widely used for assessing the severity of underlying diseases 
in patients with severe sepsis and septic shock.  
 
McCabe Class Frequency 
0 = No underlying disease 27% 
1 = Non-fatal disease or expected death within >5 years 33% 
2 = Ultimately fatal disease  or expected death within 1-5 years 30% 
3 = Rapidily fatal disease or expected death within <1 year 10% 
Table 4. Frequency of underlying diseases according to MaCabe classification among 
patients with severe sepsis (adapted from Brun-Buisson et al, Care Med 2004). 
Angus et al in a large observational study on severe sepsis (n=192,980) found that any 
underlying comorbidity occurred in 55.5% of cases, and the most prevalent coexisting 
conditions were chronic obstructive pulmonary disease (12.3%) and  nonmetastatic 
neoplasm (11.6%) (Angus, 2001). Annane et al analyzed 8,251 cases of septic shock from 22 
intensive care units and found a high proportion of patients having underlying disease with 
presumably reduced life expectancy (Annane, 2003). In this series the most common 
comorbidities were: Immune deficiency (21.9%), chronic pulmonary disease (9.2%)  
and hematologic malignancy (8.4%). Martin et al  over a 22-year period identified  10,319,418 
cases  of sepsis with a proportion of organ failure in 33.6 percent of patients during the most 
recent subperiod, resulting in the identification of 184,060 cases of severe sepsis in 1995  
and 256,033 in 2000. In this series the most frequent comorbidities were diabetes (12.2-
18,7%), hypertension (7.0-18.6%), cancer (14.5-18.0%) and congestive heart failure (8.6-
15.2%). 
The coexisting conditions represented in observational studies (Zaragoza 2003 and Artero 
2010)  are probably more representative of those in all patients with severe sepsis and septic 
shock than are the conditions documented in participants in clinical trials, from which 
patients with certain medical conditions (e.g., HIV infection, or cancer) may be excluded. In 
our series of 455 patients with severe sepsis and septic shock admitted to ICU diabetes 
mellitus was the most prevalent comorbity, followed by chronic heart failure and CPOD 
(See table 5). 
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Fig. 7. Coexistent conditions in patients with severe sepsis and septic shock (adapted from 
several large observational studies).  
5. Sources of severe sepsis and septic shock 
The lung is the primary source of infection both in severe sepsis and in septic shock, 
followed by the abdomen, the urinary tract, soft tissues and primary blood stream infection 
(Annane 2003, Blanco 2008, Kumar 2010).  The sites of infection in a series of 4,662 patients 
with septic shock is shown in figure 8, and the sites of infection in a cohort study of 192,980 
cases of severe sepsis is shown in figure 9.  
 
Comorbidities Number Percentage 
Diabetes mellitus 102 22.4 
COPD 81 17.8 
Heart failure 99 21.7 
Alcoholism 49 10.7 
Malignancy 51 11.2 
Liver cirrhosis 26 5.6 
Chronic renal insufficiency 39 8.5 
HIV 17 3.7 
Table 5. Underlying comorbidities in 455 adult patients with severe sepsis and septic shock 
in an ICU. 
Intra-abdominal and respiratory sources of sepsis have been considered as risk foci of 
infection, because these foci were associated with a higher mortality than other sources of 
sepsis. These foci have also been related to inadequate empirical antimicrobial treatment 
(Zaragoza, 2003). 
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Fig. 8. Sources of septic shock (adapted from Kumar et al, Crit Care Med 2010; 38:1773–85). 
6. Microorganisms that cause severe sepsis and septic shock 
The proportion of severe sepsis and septic shock with unidentified pathogen is about one 
third. In some studies the infection was not documented in 40% of cases, possibly due to the 
increase in empiric antibiotic treatment (Guidet 2005). The percentage of positive blood 
culture increases with the severity of the sepsis syndrome. 
Traditionally, Gram-negative bacilli - mostly represented by Escherichia coli, Pseudomonas 
aeruginosa, Klebsiella pneumonia - were more prevalent than Gram-positive cocci - 
Staphylococcus aureus, Streptococcus pneumonia, Enterococcus spp. - . However, Gram-positive 
microorganisms have become the most common microorganisms isolated in the more recent  
 
 
Fig. 9. Sources of severe sepsis (adapted from Angus et al, Crit Care Med 2001; 29:1303–10). 
studies (Guidet, 2005). The percentage of polymicrobial infection as well as the proportion of 
multiresistant bacteria like Pseudomonas and methicillin-resistant Staphylococci, has 
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significantly increased over time (Annane 2003). The incidence of fungi has also been 
reported to be increasing in recent years. 
 
 
Fig. 10. Cases of severe sepsis according to the causative origin (adapted from Martin et al 
New Engl J Med 2003;348:1546-1554). 
Age influence the etiology of severe sepsis and septic shock in the pediatric population. 
During the neonatal period the most frequent microorganisms isolated are group B 
streptococci and enteric bacilli, such as Escherichia coli. Listeria monocytogenes, enterococci, 
Haemophilus influenzae, and Streptococcus pneumoniae are less common pathogens isolated. 
The incidence of coagulase-negative staphylococci, Staphylococcus aureus, gram-negative 
bacilli, and fungi are increasing in the pediatric population as a consequence of the advances 
in neonatology. S. pneumoniae, Neisseria meningitidis,and H. influenzae type B are common 
pathogenes beyond the neonatal period.  
Immunodeficiency predispose children to some specific microorganisms, such as gram-
negative bacteria, alpha-hemolytic streptococci, Viridans group streptococci and 
cytomegalovirus in neutropenic patients; Streptococcus pneumoniae,P. aeruginosa, 
Staphylococcus aureus, and Haemophilus influenza type B in patients with acquired 
immunodeficiency virus; and Streptococcus pneumoniae, Salmonella spp., Haemophilus influenza 
type B, and N. meningitides in patients with asplenia.  
7. Morbidity 
Half of severe sepsis survivors are readmitted to hospital within a year, and their quality of 
life is comparable with survivors of polytrauma. Jagodič et al studied the long-term survival 
and quality of life of patients treated in a surgical ICU because of sepsis or trauma, and 
found that the quality of life (assessed after 2 years following ICU admission using the 
EuroQol 5D questionnaire) was reduced to the same level in both groups (see figure 12), and 
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82% of patients reported a problem (moderate or extreme) in at least one dimension of 
EuroQol 5D (Jagodič, 2006).  
 
 
Fig. 11. Quality of life of 164 patients with sepsis or trauma after 2 years following ICU 
admission using the EuroQol 5D questionnaire (Jagodič et al, Crit Care 2006). 
Acute respiratory distress syndrome, myocardial dysfunction, acute renal failure and 
chronic dysfunction, disseminated intravascular coagulation (DIC), and liver failure are all 
significant sequels of severe sepsis and septic shock. Furthermore, recent evidence shows 
that septic shock in elderly persons leads to significant long-term cognitive and functional 
disability as a consequence of prolonged tissue hypoperfusion (Iwashyna 2010). 
8. Mortality 
The Centers for Disease Control and Prevention has estimated that sepsis is the tenth 
leading cause of death overall in the United States (Hoyert 2001). Severe sepsis is considered 
to be the most common cause of death in noncoronary critical care units. The deaths related 
to severe sepsis exceed the numbers of persons with other diseases that attract higher public 
awareness, such as breast cancer and AIDS (Moss 2005). The mortality rates of severe sepsis 
and septic shock are 25 to 30% and 40 to 70%, respectively.  
The mortality rate according to sepsis diagnostic criteria in shown in figure 12.  
In this picture the global in-hospital mortality rate in 624 patients with sepsis syndromes 
admitted to the ICU in our hospital was 37.7%, 55.9% and 66.2% in sepsis, severe sepsis and 
septic shock, respectively. However the related mortality to infection was quite a few lower 
(7.7%, 16.7% and 30.1% in sepsis, severe sepsis and septic shock, respectively).  
The crude mortality rate of septic shock  is decreasing, but patients with septic shock still 
have a high excess risk of death than critically ill patients who are nonseptic. Annane et al in 
an epidemiological study analyzed 100,554 intensive care unit admissions on the Collège 
des Utilisateurs de Bases de données en Réanimation (CUB-Re´a) database, collected from 
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22 hospitals over a 8-year period, 1993 to 2000, and found an overall frequency of septic 
shock of 8.2 per 100 admissions, and a crude mortality of 60.1% and declined from 62.1% (in 
1993) to 55.9 (in 2000) (p < 0.001). As compared with matched intensive care unit admissions 
without sepsis, the excess risk of death due to septic shock was 25.7 (95% confidence 
interval, 24.0–27.3) and the matched odds ratio of death was 3.9 (95% confidence interval, 
3.5–4.3) (Annane, 2003). 
 
 
Fig. 12. Mortality rate according to sepsis diagnostic criteria. 
The severity of severe sepsis and septic shock do not markedly depend on the source  
of infection or on its causative microorganism. On the contrary, mortality is directly 
related to the occurrence of organ failure in sepsis, and this relationship has remained 
consistent among patients of different races and sexes. However, organ failure scores  
may have difficulty quantifying the contribution that preexisting organ dysfunction adds 
to risk. 
The patient’s underlying comorbidities are directly related to mortality in several studies. 
The index of McCabe and Jackson is one of the most useful scores used in epidemiological 
and clinical studies to quantify underlying consitions. APACHE II, Simplified Acute 
Physiology Score (SAPS II) and the sequential organ failure assessments (SOFA) are 
prognostic scores based on bedside evaluation which are widely used to predict the 
prognosis of severe sepsis and septic shock. 
The hospital mortality of severe sepsis is about 30% according to several studies, but this 
rate has been found much lower in children and previously healthy adults. Mirzanejad et al 
found that mortality from pneumococcal bacteremia varied from 3.2% in children to 43% in 
the elderly (Mirzanejad, 1996). This fact suggest attributable mortality of sepsis may be 
much less than the commonly observed 30% and that the mechanism by which sepsis causes 
death is highly dependent on individual patient factors, many of which may not be 
reversible by single antisepsis agents (Angus, 2001). 
Patients with sepsis who had any organ failure have higher mortality. Besides, organ failure 
has a cumulative effect on outcomes:  mortality in patients without organ failure is 
approximately 15 percent, whereas it reaches 70 percent in  patients with three or more 
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failing organs (classified as having severe sepsis and septic shock). The organs that failed 
most frequently in patients with sepsis are shown in figure 13. 
 
Organ failure
lungs
kidneys
cardiovasular
hematologic
metabolic
neurologic
 
Fig. 13. Organs that fail most frequently in patients with sepsis. 
Predictors of mortality in severe sepsis and septic shock in community acquired blood 
stream infectios are shown in table 3. In this study (Artero 2010) the global mortality rate 
was 41.9%, 44.5% in community acquired septic shock and 34.4% in severe sepsis, and by 
univariate analysis, age, Acute Physiology and Chronic Health Evaluation II score, at least 3 
organ dysfunctions, and albumin differed significantly between survivors and 
nonsurvivors. Acute Physiology and Chronic Health Evaluation II (odds ratio, 1.13; 95% 
confidence interval, 1.06-1.21) and albumin (odds ratio, 0.34; 95% confidence interval, 0.15-
0.76) were independent predictors of global mortality in logistic regression analysis. 
 
 
Total 
(n=112)
Hospital 
Survivors 
(n=65) 
Hospital 
Nonsurvivors
(n=47) 
OR (95%CI) P 
Mean age, y 
COPD 
Mean APACHE II 
≥3 organ dysfunctions
Unknown source 
Albumin <20g/L 
63.5 
19 
22.0 
56 
15 
27 
61.0 
7 
18.7 
19 
5 
10 
67.1 
12 
26.5 
37 
10 
17 
1.02 (1.00-1.05) 
2.84 (1.02-7.89) 
1.16 (1.08-1.23) 
3.70 (2.04-6.68) 
3.24(1.02-10.23) 
2.85 (1.11-7.33) 
.047 
.045 
<.001 
<.001 
.045 
.026 
Table 6. Predictors of mortality in severe sepsis and septic shock in community acquired 
blood stream infections (Adapted from Artero et al, J Crit Care 2010). 
Recent antibiotic exposure has been associated with increased hospital mortality in Gram-
negative bacteremia complicated by severe sepsis or septic shock (Johnson, 2011). A likely 
explanation for the association between hospital mortality and prior antibiotic exposure is 
the greater degree of antimicrobial resistance in the causative pathogen(s) of patients 
receiving prior antibiotics. Clinicians caring for patients with severe sepsis or septic shock 
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should consider recent antibiotic exposure when formulating empiric antimicrobial 
regimens for suspected Gram-negative bacterial infection. 
Boussekey et al in a five-year observational study in an ICU identified six independent 
mortality risk factors in septic shock: mechanical ventilation (OR = 4.97), Simplify Acute 
Physiology Score (SAPS) II > 60 (OR = 4.28), chronic alcoholism (OR = 3.38), age >65 years 
(OR = 2.65), prothrombin ratio <40% (OR = 2.37), and PaO2/FiO2 ratio <150 (OR = 1.91). The 
identification of these risk factors recovered in the multivariate analysis can easily be 
available on admission and allow screening immediately a group of patients with a high 
mortality risk in septic shock (Boussekey, 2010). 
Mortality of sepsis appears to be higher in ICU-acquired sepsis than in community-acquired 
sepsis. Vincet et al described a direct relationship between intensive care unit mortality rates 
for all patients and frequency of sepsis in various European countries (Vincent, 2006). 
Winters et al performed a systematic review of studies reporting long-term mortality and 
quality-of-life data (>3 months) in patients with severe sepsis and septic shock using defined 
search criteria and found that patients with sepsis showed ongoing mortality up to 2 yrs and 
beyond after the standard 28-day inhospital mortality end point.  Patients with sepsis also 
had decrements in quality-of-life measures after hospital discharge (Winters, 2010). 
9. Cost of care 
The information on the cost of care of patients with severe sepsis and septic shock is quite 
scarce. The cost of care for patients with sepsis has been related to their length of stay in the 
intensive care unit and hospital. However, several studies have found that many patients with 
sepsis did not receive intensive care unit care. The length of stay for patients with severe sepsis 
has been reported to be twice higher than in sepsis (Brun-Buisson, 2004). The average total cost 
per intensive care unit day is estimated at approximately 1200 Euro for countries with a highly 
developed healthcare system (based on various studies conducted between 1989 and 2001 and 
converted at 2003 currency rates). US cost-of-illness studies focusing on direct costs per sepsis 
patient have yielded estimates of 34,000 Euro, whereas European studies have given lower 
cost estimates, ranging from 23,000 Euro to 29,000 Euro (Burchardi, 2004). 
The introduction of new biotechnology products to treat patients with severe sepsis and 
septic shock should also be considered in cost analysis. In order to achieve the greatest 
benefits from these drugs they should be used in selected patients.  
Indirect costs associated with severe sepsis account for 70-80% of costs and arise mainly 
from productivity losses due to mortality. Sepsis is an acute disease and so most studies of 
sepsis have been done in the hospital environment. However, other important factor related 
to the cost of care is the long-term sequels of sepsis, which unfortunately is not usually 
taken into account. 
The cost of care of patients with sepsis presents notable variation among hospitals, and there 
is not good correlation between cost and mortality. Recently, Lagu et al in a large 
multicenter study analyzed data from 166,931 patients with sepsis found that hospital 
spending and adjusted mortality rates for patients with sepsis vary substantially, and higher 
hospital expenditures are not associated with better survival (Lagu, 2011).  
10. Conclusion 
Severe sepsis and septic shock have a significant and increasing impact on public health, 
and are one of the leading causes of mortality. Studies done in the last decades have shown 
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that the incidence of these syndromes has increased over the last thirty years, with an 
increasing number of deaths occurring despite a decline in overall in-hospital mortality. 
The definitions of sepsis syndromes established in 1992 and 2001 have contributed to 
improve not only epidemiological research, but also bedside diagnosis. Severe sepsis is 
defined as the presence of sepsis (systemic inflammatory response + probable or confirmed 
infection); severe sepsis defined as sepsis + acute organ dysfunction, hypoperfusion 
abnormality, or transient hypotension, independent of other cause than sepsis; and septic 
shock is defined as sepsis + hypotension persisting for more than 1 hour despite adequate 
fluid resuscitation. The syndromes of sepsis can be seen as a continuum of severity that 
starts with an infection and can progress to septic shock.  However, these definitions are not 
good enough tools to predict outcomes.  
The epidemiology of severe sepsis and septic shock is not well known mainly due to the 
absence of population base prospective cohort studies. Reported rates of severe sepsis from 
different studies ranged from 50 to 104 per 100.000 population, with an incidence of 
300/100.000 in a single study from the United States (Angus, 2001). However, the incidence 
of severe sepsis in this last study could have been overstated due to the authors used ICD-9-
CM coding for the identification of the syndromes. The prevalence of severe sepsis and 
septic shock in patients admitted to intensive care units is 11-30% and 6-10%, respectively. 
Studies using data from admissions to emergency departments and intensive care units 
have also found increasing rates of severe sepsis and septic shock in the last decades. 
The increasing aging of the population and the increased prevalence of underlying 
comorbidities in developed countries are the main variables influencing the incidence of 
severe sepsis and septic shock. The relative risk for sepsis is thirteen times higher for 
patients aged 65 and above than in younger patients. Escherichia coli has been found to be the 
most frequent microorganism in patients older than 65 years, and urinary tract infection the 
most frequent source of infection in older population. Patients with severe sepsis and septic 
shock frequently have coexisting conditions, such as chronic pulmonary diseases, immune 
deficiency, malignancy or diabetes mellitus. McCabe classification has been widely used in 
epidemiological studies to assess comorbidities which predispose patients to infections and 
may have an additive contribution to mortality.  
Black people have a higher incidence of severe sepsis and septic shock than white people, 
and the age of black population with these disorders is lower than the age of white people. 
There is no consensus about whether the worse outcomes of black people with severe sepsis 
and septic shock is due to genetic factors or a higher prevalence of subjacent comorbidities 
in black population. 
Men have a higher prevalence of severe sepsis and septic shock than women.  The fact that 
this lower rate of sepsis syndromes observed in women is present over all range of age 
argues against the gender differences being solely mediated through sex hormones.  
Respiratory infections are the major source of severe sepsis and septic shock, which is more 
prevalent in men than in women, followed by intra-abdominal infections, urinary tract 
infections and primary bloodstream infections. Respiratory infections and abdominal 
infections appear to have a worse prognosis than other foci.  
Gram-positive cocci have become the most common microorganisms over the past decades, 
taking precedence over Gram-negative bacilli. The proportion of fungi and multiresistant 
bacteria (multiresistant Pseudomonas spp, methicillin-resistant Staphylococci …) has 
significantly increased over the last few years, which has contributed to increase the rates of 
inappropriate empirical antimicrobial treatment. 
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The mortality rates of severe sepsis and septic shock are 25 to 30% and 40 to 70%, 
respectively. Sepsis is the tenth leading cause of overall death in the United States and 
severe sepsis is the most common cause of death in noncoronary critical care units. There are 
several independent risk factors of mortality of severe sepsis and septic shock. Among these, 
the number of organ failures (commonly assessed by SOFA), the underlying comorbidities 
and the severity of acute illness (APACHE II) are the most constantly identified in 
epidemiological studies. The quality of life of survival patients of sepsis assessed after 2 
years from admission to intensive care unit is markedly reduced, with more than 80% of 
patients reporting a problem. 
The direct cost of care for patients with severe sepsis is about 30,000 Euro, with notable 
variations among hospitals and without good relationship between cost and mortality. The 
length of stay in intensive care unit and hospital are the major determinants of cost. 
However, 75% of the global cost is dependent of indirect cost, which is mainly caused by 
productivity losses due to mortality. Besides, the cost of long-term sequels is not usually 
included in cost-effectiveness analysis of severe sepsis and septic shock.    
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